At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Not specified by the sponsor
- How long the study runs
- Study runs about 23 months (dates as stated)
- About the drug or intervention
- Not specified by the sponsor
- Patient visit burden
- Not specified by the sponsor
In plain English
This is a real-world study run by AbbVie. It looks at how three skin and hair conditions affect people's lives: non-segmental vitiligo (NSV, a condition causing pale patches of skin), alopecia areata (AA, hair loss), and hidradenitis suppurativa (HS, painful lumps under the skin). The study aims to assess the overall burden of these conditions in teenagers and adults around the world.
Who can take part
- A doctor has confirmed you have non-segmental vitiligo (NSV), or moderate to severe alopecia areata (AA), or moderate to severe hidradenitis suppurativa (HS)
- You can understand the study questionnaires, with help from a carer if needed for teenagers
Who may not be able to
- You are taking part in an interventional clinical trial (one that tests a treatment) at the time of the study visit — taking part in another non-interventional study or registry does not rule you out
- You cannot or do not want to follow the study requirements and complete the patient questionnaires
What taking part involves
- • Not stated — ask the trial team
Time commitment: Not stated — ask the trial team. The study involves completing questionnaires (patient-reported outcomes), with caregiver support for adolescents if needed.
Plain-English summary (AI-generated) from registry data. Not eligibility advice — only the trial team can confirm whether you can take part. Use the eligibility checker to see how your health profile matches this trial.
- Type of study
- Observing health over time
- Ages
- 12 Years and over
- Who
- All
- Number of participants
- 2,795
- Started
- 2025-09-02
- Last checked
- 2026-02
Plain English Summary
What is this study?
- • Testing a new treatment for non-segmental vitiligo (nsv)
- • Clinical study - 2,795 participants
- • This study is to assess the burden of disease in adolescent and adult participants with moderate or severe alopecia areata (AA), non-segmental vitiligo (NSV), or moderate to severe hidradenitis suppurativa (HS) in a large global real-world participant population
Who can take part?
- • Ages 12 Years and over
- • Diagnosed with non-segmental vitiligo (nsv)
Where?
- • London - University Hospital Lewisham /ID# 279233
- • Oxford - Oxford University Hospitals - John Radcliffe Hospital /ID# 279052
- • Leeds - Leeds Teaching Hospitals NHS Trust /ID# 278524
- • Wakefield - Mid Yorkshire Teaching NHS Trust /ID# 279190
- • +4 more UK sites
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
This study is to assess the burden of disease in adolescent and adult participants with moderate or severe alopecia areata (AA), non-segmental vitiligo (NSV), or moderate to severe hidradenitis suppurativa (HS) in a large global real-world participant population.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 12 Years and over
- Who can join: All genders
Treatment history
Treatments you must have had:
- ✓ for adolescents
What the study is looking for
- ✓Participants with Physician-confirmed diagnosis of non-segmental vitiligo (NSV), moderate to severe Alopecia Areata...
- ✓Participants Ability to understand study questionnaires, with caregiver support as required for adolescents
Who cannot take part
- ✗Participating in interventional clinical trial(s) at time of study visit (participation in another...
- ✗Unable or unwilling to comply with study requirements and PRO collection
See the full criteria
Where Is This Study? (8 UK sites)
University Hospital Lewisham /ID# 279233
London SE13 6LH, United Kingdom
Oxford University Hospitals - John Radcliffe Hospital /ID# 279052
Oxford OX3 9DU, United Kingdom
Leeds Teaching Hospitals NHS Trust /ID# 278524
Leeds LS9 7TF, United Kingdom
Mid Yorkshire Teaching NHS Trust /ID# 279190
Wakefield WF1 4DG, United Kingdom
Ulster Hospital - South Eastern Health & Social Care Trust /ID# 279191
Belfast BT16 1RH, United Kingdom
Cardiff and Vale UHB /ID# 278856
Cardiff CF14 4XW, United Kingdom
Walsall Manor Hospital /ID# 279240
Walsall WS2 9PS, United Kingdom
New Cross Hospital /ID# 279202
Wolverhampton WV10 0QP, United Kingdom
How to Get in Touch
Beth Rycroft
Sponsor contactCONTACT
